International Conference on HIV Treatment and Prevention Adherence 2012

CONFERENCE EDUCATIONAL CONTENT

This conference will provide a forum where the state-of-the-science for HIV treatment and biomedical prevention adherence research will be presented, discussed, and translated into evidence-based approaches. The 2.5-day program will allow healthcare and human service professionals to examine evidence-based, practical strategies to enhance and maintain adherence to HIV treatment and biomedical prevention interventions in a variety of domestic and international settings.

CONFERENCE EDUCATIONAL OBJECTIVES

After attending this conference, participants will be able to:

-Identify successes and challenges in achieving treatment success, including optimal HIV treatment adherence and mitigating HIV drug resistance, in various settings and populations worldwide

-Explain behavioral, clinical and structural aspects of adherence that reflect a variety of HIV treatment team

perspectives (e.g., patients, physicians, pharmacists, nurses, mental health professionals, adherence specialists)

-Describe current perspectives on biomedical prevention interventions, including pre-exposure prophylaxis (PrEP) and antiretroviral-based microbicides

-Discuss the implications of HIV treatment and biomedical prevention adherence for individual, community and public health

-Utilize adherence assessment tools and interventions that can be integrated into patient care and/or as components of prevention interventions